EirGenix’s Phase III Clinical Trial of EG12014 Has Enrolled First Patient
2018 Biologics Manufacturing Korea
Cancer Therapeutic Drug EG12014 Is Approved For Phase III Clinical Trial
EirGenix Is Award Top 145 Of The Technology Fast 500 Companies In Asia Pacific (APAC)
EirGenix Received “Asia’s Best CMO”
Eirgenix Received The Accreditation Certificate Of Foreign Drug Manufacturer From Japan
Eirgenix held the whole New “Protein Drug Commercial Production Plant” beam-raising ceremony
Cancer Therapeutic Drug EG12014 Passed the Double-Blinded Phase I Clinical Trial
EirGenix Received “Grand Winner of Best Bioprocess Excellence In Taiwan”